PVNS clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This study, designed as a proof of concept study of MCS110 in pigmented villonodular synovitis, will assess the clinical response to MCS110 treatment in newly diagnosed Pigmented Villonodular Synovitis (PVNS) patients within 4 weeks after a single intravenous dose of MCS110 using magnetic resonance imaging to assess tumor volume, and to evaluate pharmacokinetics/pharmacodynamics, safety and tolerability in this population.
San Diego, California and other locations